Medical device maker Covidien Plc said it would cut costs by outsourcing services to low-cost locations and consolidating manufacturing and distribution centers.
The company said it expects to record related charges of about $350 million to $450 million, most of which will be incurred by the end of fiscal 2018.
Continue Reading Below
Covidien said the restructuring, which has been approved by its board, is expected to save about $250 million to $300 million annually, with savings beginning in fiscal 2014 and accelerating in fiscal 2015.
The company expects a large portion of the restructuring to be completed by the end of fiscal 2018.
(Reporting by Esha Dey in Bangalore; Editing by Saumyadeb Chakrabarty)